Use of Vasopressin Following the Fontan Operation

Phase 2/3 Completed 12 enrolled Wake Forest University Health Sciences

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this pilot study is to prepare for a larger study to determine whether Vasopressin following the Fontan operation will decrease chest tube output and duration.

Timeline

Start: 2016-12
Primary completion: 2019-12
Completion: 2019-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Vasopressin	Peptide	0.4 unknown	—

Use of Vasopressin Following the Fontan Operation

Summary

Timeline

Drugs

Indications